Michelle Morrow
Granta Design (United Kingdom)(GB)e-Therapeutics (United Kingdom)(GB)Avacta (United Kingdom)(GB)NuvOx Pharma (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer, Hypoxia, and Metabolism, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade(2014)1,281 cited
- → Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery(2016)412 cited
- → Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody(2015)402 cited
- → Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade(2017)360 cited
- → Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells(2021)175 cited
- → ERG Is a Megakaryocytic Oncogene(2009)116 cited